Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Targetnews2024-12-02T01:11:12+00:00December 2nd, 2024|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Criticsnews2024-11-27T08:00:11+00:00November 27th, 2024|The New York Times|
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposalnews2024-11-26T21:15:23+00:00November 26th, 2024|The New York Times|
A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respectonews2024-11-26T08:00:57+00:00November 26th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Knownews2024-11-22T21:06:45+00:00November 22nd, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Don’t Blame Biden for Trump’s Victorynews2024-11-15T15:38:02+00:00November 15th, 2024|The New York Times|
What Democrats Should Learn From Their Lossnews2024-11-13T16:49:52+00:00November 13th, 2024|The New York Times|
